-
Subject Areas on Research
-
1982 resident's essay award: the immunologic effects of lymphoid irradiation in human and non-human primates: cellular changes and the potential for renal transplantation.
-
5-Fluorouracil in childhood solid tumors.
-
A case of vanishing bile duct syndrome and IBD secondary to Hodgkin's lymphoma.
-
A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
-
A monoclonal IgM with antibodylike specificity for phospholipids in a patient with lymphoma.
-
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.
-
A pilot study of etoposide, vinblastine, and doxorubicin plus involved field irradiation in advanced, previously untreated Hodgkin's disease.
-
A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
-
A sinusoidal large cell lymphoma with expression of CD30, CD15, and multiple B-cell antigens: a classical Hodgkin lymphoma with sinusoidal infiltrating pattern or a sinusoidal CD30 positive large B-cell lymphoma with CD15?
-
A+AVD versus eBEACOPP in advanced-stage Hodgkin lymphoma.
-
Acquisition of CD30 and CD15 accompanied with simultaneous loss of all pan-T-cell antigens in a case of histological transformation of mycosis fungoides with involvement of regional lymph node: an immunophenotypic alteration resembling classical Hodgkin lymphoma.
-
Adult respiratory distress syndrome after limited thoracic radiotherapy.
-
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.
-
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
-
An Epstein-Barr virus-positive classical Hodgkin lymphoma with exclusive sinusoidal growth pattern: An unusual morphologic variant.
-
An exploratory study of environmental and medical factors potentially related to childhood cancer.
-
Atypical presentation of pneumococcal pneumonia in a patient undergoing bone marrow transplantation for Hodgkin's disease.
-
Bone marrow transplantation. Part II--autologous.
-
Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases.
-
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
-
CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells.
-
Chemotherapy or Combined Modality Therapy for Early-stage Hodgkin Lymphoma.
-
Childhood Hodgkin Lymphoma: Think DADA2.
-
Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases.
-
Climate, socioeconomic status and Hodgkin's disease mortality in the United States.
-
Clinical, Imaging Findings, Responses, and Outcomes of Patients With Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma Undergoing Immune Checkpoint Inhibitor Therapy: A Single-Institution Experience.
-
Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma.
-
Combined-modality therapy for early-stage Hodgkin lymphoma: maintaining high cure rates while minimizing risks.
-
Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
-
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B.
-
Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
-
Consolidation Radiation Therapy for Patients With Advanced Hodgkin Lymphoma in Complete Metabolic Response According to PET-CT or Gallium Imaging.
-
Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients.
-
Cryptococcal meningitis with normal cerebrospinal fluid.
-
Cytomegalovirus retinitis associated with Hodgkin's disease.
-
Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells.
-
Differentiation of radiation fibrosis from recurrent neoplasia: a role for 31P MR spectroscopy?
-
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.
-
Dynamic assessment of quality of life after autologous bone marrow transplantation.
-
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma.
-
Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT.
-
Effects of nitrogen mustard and splenectomy on mouse bone marrow colony formation in vitro.
-
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.
-
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
-
Enlargement of mediastinal masses on simulation films: a radiotherapeutic problem in the management of patients with Hodgkin's disease.
-
Epidural spinal compression as an initial presentation of Hodgkin lymphoma.
-
Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity.
-
Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.
-
Esophageal disease among childhood cancer survivors-A report from the Childhood Cancer Survivors Study.
-
Exercise and risk of major cardiovascular events in adult survivors of childhood hodgkin lymphoma: a report from the childhood cancer survivor study.
-
Experts on their own experiences: the rise of patient-reported outcomes in oncology drug trials.
-
Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
-
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
-
Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
-
G-CSF and peripheral blood progenitor cells.
-
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
-
Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
-
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy.
-
HL-A antigenic loss in malignant transformation.
-
Hair regrowth after cancer therapy.
-
Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133.
-
Height at diagnosis of malignancies.
-
High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.
-
High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.
-
High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes.
-
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.
-
High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
-
High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.
-
High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.
-
Hodgkin Lymphoma Survivors: We Need to Do Better.
-
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
-
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
-
Hodgkin disease/lymphoma.
-
Hodgkin disease/lymphoma. Clinical practice guidelines in oncology.
-
Hodgkin disease: clinical utility of CT in initial staging and treatment.
-
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration.
-
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.
-
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.
-
Hodgkin lymphoma, version 2.2015.
-
Hodgkin lymphoma.
-
Hodgkin's disease presenting as myelofibrosis.
-
Hodgkin's disease treated with neck radiation is associated with increased antibody-dependent cellular cytotoxicity against human extraocular muscle cells.
-
Hodgkin's lymphoma and tumor necrosis factor inhibitors in juvenile idiopathic arthritis.
-
Hodgkin's lymphoma of the breast.
-
How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
-
Ig-positive lymphocytes in Hodgkin's disease.
-
Imaging of late complications from mantle field radiation in lymphoma patients.
-
Immune-related Neurological Symptoms in an Adolescent Patient Receiving the Checkpoint Inhibitor Nivolumab.
-
Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study.
-
Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
-
Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease.
-
Improved survival in advanced Hodgkin's disease with the use of combined modality therapy.
-
In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma.
-
Incidence of anemia in children with solid tumors or Hodgkin disease.
-
Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan.
-
Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.
-
Inhibiting inhibitory pathways in human γδ T cells.
-
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?
-
Interstitial hyperthermia in combination with brachytherapy.
-
Intra-abdominal desmoid tumor after successful treatment for Hodgkin disease.
-
Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood.
-
Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy.
-
Long-term follow-up of Hodgkin's disease trial.
-
Long-term follow-up of survival in Hodgkin's lymphoma.
-
Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
-
Lymphoid enhancer binding factor 1 (LEF1) expression is significantly higher in Hodgkin lymphoma associated with Richter syndrome relative to de novo classic Hodgkin lymphoma.
-
Malignant (Diffuse) Mesothelioma in Patients With Hematologic Malignancies: A Clinicopathologic Study of 45 Cases.
-
Malignant peripheral nerve sheath tumor of the spine after radiation therapy for Hodgkin's lymphoma.
-
Management of reproductive health in Cowden syndrome complicated by endometrial polyps and breast cancer.
-
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
-
Mediastinal Lymphoproliferative Disorders.
-
Mediastinal bulk in Hodgkin disease. Method of measurement versus prognosis.
-
Modifiable risk factors for neurocognitive and psychosocial problems after Hodgkin lymphoma.
-
Multifocal nodular episcleritis and scleritis with undiagnosed Hodgkin's lymphoma.
-
Multimodality surgical and hyperbaric management of mandibular osteoradionecrosis.
-
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
-
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.
-
Nodular lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component.
-
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.
-
Patient-reported distress in Hodgkin lymphoma across the survivorship continuum.
-
Pediatric Hodgkin Lymphoma, Version 3.2021.
-
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning.
-
Pharmacokinetics of high-dose oral CCNU in bone marrow transplant patients.
-
Primary Mediastinal Classical Hodgkin Lymphoma.
-
Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 1.
-
Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 2.
-
Primary intracerebral Hodgkin lymphoma with recurrence.
-
Primary mediastinal (thymic) large B-cell lymphoma: a short review with brief discussion of mediastinal gray zone lymphoma.
-
Prognostic importance of restaging gallium scans following induction chemotherapy for advanced Hodgkin's disease.
-
Promoting Breast Cancer Surveillance: The EMPOWER Study, a Randomized Clinical Trial in the Childhood Cancer Survivor Study.
-
Proton radiotherapy for Hodgkin's disease in the sacrum.
-
Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
-
Radiation techniques for the treatment of Hodgkin's disease with combined modality therapy or radiation alone.
-
Radiation-associated valvular heart disease.
-
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.
-
Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer.
-
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
-
Results of treatment of stage 3A Hodgkin's disease.
-
Results of treatment of stage IA and IIA Hodgkin's disease.
-
Retinopathy and optic neuropathy after transplantation.
-
Retroperitoneal fibrosis following treatment for Hodgkin's disease.
-
Rituximab in lymphocyte predominance Hodgkin's disease: a case series.
-
Salvage therapy in Hodgkin's lymphoma.
-
Sarcoma of bone and soft tissue following treatment of Hodgkin's disease.
-
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.
-
Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation.
-
Self-administration of morphine in bone marrow transplant patients reduces drug requirement.
-
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
-
Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma.
-
Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.
-
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study.
-
Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208.
-
Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.
-
Solid tumor second primary neoplasms: who is at risk, what can we do?
-
Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG.
-
Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
-
Steroid premedication before i.v. contrast-enhanced CT resulting in resolution of lymphadenopathy.
-
Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study.
-
Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.
-
Successful fertilization and pregnancy outcome in in-vitro fertilization using cryopreserved/thawed spermatozoa from patients with malignant diseases.
-
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer.
-
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary data.
-
The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance).
-
The biology of human lymphoid malignancies revealed by gene expression profiling.
-
The cost-benefit ratio of the cure of Hodgkin's disease.
-
The effect of patient-specific factors on radiation-induced regional lung injury.
-
The effect of the respiratory cycle on mediastinal and lung dimensions in Hodgkin's disease. Implications for radiotherapy gated to respiration.
-
The efficacy-toxicity conundrum: breaking the mold.
-
The patient experience of ABVD treatment in Hodgkin lymphoma: a retrospective cohort study of patient-reported distress.
-
The pattern of intrathoracic Hodgkin's disease assessed by computed tomography.
-
The significance of necrotic mediastinal lymph nodes on CT in patients with newly diagnosed Hodgkin disease.
-
The third-generation anti-CD30 CAR T-cells specifically homing to the tumor and mediating powerful antitumor activity.
-
Three months in the symptom life of a teenage girl undergoing treatment for cancer.
-
Thyroid nodules and survivors of Hodgkin's disease.
-
Total lymphoid irradiation as an immunosuppressive agent for transplantation and the treatment of 'autoimmune' disease: a review.
-
Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: sensitivity and specificity of the Ann Arbor staging procedure criteria.
-
Upper extremity lymphangiography as an aid to treatment planning for stage 1A epitrochlear hodgkin's disease.
-
Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.
-
Virtual bronchoscopy for directing transbronchial needle aspiration of hilar and mediastinal lymph nodes: a pilot study.
-
Virtual reality as a distraction intervention for older children receiving chemotherapy.
-
[Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases].